MCD(MCD)
MCD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $28.07B | $29.67B | $30.92B | $32.08B | $32.14B |
| Low | $27.72B | $29.03B | $29.83B | $31.33B | $31.39B |
| High | $28.31B | $30.04B | $31.89B | $32.73B | $32.79B |
| EBITDA Avg | $14.72B | $15.55B | $16.21B | $16.82B | $16.85B |
| Low | $14.53B | $15.22B | $15.64B | $16.42B | $16.45B |
| High | $14.84B | $15.75B | $16.72B | $17.16B | $17.19B |
| EBIT Avg | $12.47B | $13.18B | $13.73B | $14.25B | $14.28B |
| Low | $12.32B | $12.90B | $13.25B | $13.92B | $13.94B |
| High | $12.58B | $13.35B | $14.17B | $14.54B | $14.57B |
| Net Income Avg | $9.18B | $9.91B | $10.58B | $11.42B | $11.84B |
| Low | $9.11B | $9.77B | $10.20B | $11.07B | $11.48B |
| High | $9.36B | $10.25B | $11.12B | $11.72B | $12.15B |
| EPS Avg | $12.92 | $13.97 | $14.96 | $15.94 | $16.53 |
| Low | $12.71 | $13.64 | $14.23 | $15.46 | $16.03 |
| High | $13.06 | $14.31 | $15.52 | $16.36 | $16.96 |
| Analysts (Rev / EPS) | 21 / 19 | 24 / 21 | 17 / 11 | 13 / 4 | 8 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $7.34B | $7.30B | $6.80B | $7.45B | $7.72B | $7.69B | $7.11B | $7.71B |
| Low | $7.23B | $7.20B | $6.68B | $7.32B | $7.58B | $7.55B | $6.99B | $7.58B |
| High | $7.41B | $7.38B | $6.89B | $7.54B | $7.82B | $7.79B | $7.20B | $7.81B |
| EBITDA Avg | $3.85B | $3.83B | $3.57B | $3.91B | $4.05B | $4.03B | $3.73B | $4.04B |
| Low | $3.79B | $3.77B | $3.50B | $3.84B | $3.98B | $3.96B | $3.66B | $3.97B |
| High | $3.88B | $3.87B | $3.61B | $3.95B | $4.10B | $4.08B | $3.78B | $4.09B |
| EBIT Avg | $3.26B | $3.24B | $3.02B | $3.31B | $3.43B | $3.42B | $3.16B | $3.43B |
| Low | $3.21B | $3.20B | $2.97B | $3.25B | $3.37B | $3.36B | $3.10B | $3.37B |
| High | $3.29B | $3.28B | $3.06B | $3.35B | $3.47B | $3.46B | $3.20B | $3.47B |
| Net Income Avg | $2.43B | $2.36B | $2.16B | $2.52B | $2.65B | $2.59B | $2.32B | $2.69B |
| Low | $2.39B | $2.33B | $2.11B | $2.46B | $2.59B | $2.53B | $2.26B | $2.62B |
| High | $2.50B | $2.41B | $2.20B | $2.56B | $2.69B | $2.63B | $2.36B | $2.73B |
| EPS Avg | $3.41 | $3.31 | $3.03 | $3.53 | $3.71 | $3.62 | $3.25 | $3.76 |
| Low | $3.35 | $3.26 | $2.96 | $3.45 | $3.63 | $3.54 | $3.17 | $3.68 |
| High | $3.51 | $3.38 | $3.08 | $3.59 | $3.77 | $3.68 | $3.30 | $3.83 |
| Analysts (Rev / EPS) | 16 / 17 | 16 / 17 | 9 / 7 | 8 / 15 | 8 / 9 | 13 / 7 | 8 / 9 | 7 / 8 |